Novel use of processed ginseng

A ginseng and process technology, applied in the field of organ lipid lowering agents and ethanol metabolism promoters, can solve the problems of insufficient metabolism of ethanol, trouble in daily life, etc., and achieve the effects of preventing and improving lifestyle diseases and preventing and improving headaches.

Inactive Publication Date: 2010-09-22
WAKUNAGA PHARMA CO LTD
View PDF8 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, ethanol may not be metabolized sufficiently due to excessive drinking or individual differences in metabol

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel use of processed ginseng
  • Novel use of processed ginseng
  • Novel use of processed ginseng

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062] Weigh 100 g of Tianqimo (manufactured by Yunnan Baiyao Group Co., Ltd.) and 5 g of the enzyme lactase F "Amano" (manufactured by Amano Enzyme Co., Ltd.) derived from Aspergillus oryzae, and add 2.5 1 liter of water to dissolve and suspend it, place it in an incubator at 50° C., shake it from time to time, and allow it to react for 7 days. Then, add acetic acid, make the concentration of acetic acid be 1v / v%, and carry out heat treatment (120 ℃, 1 hour) to make it react, make enzyme inactivation simultaneously, this reaction solution is directly freeze-dried, obtains brown powder 113 grams (sample 1).

Embodiment 2

[0064] Weigh 100 g of ginseng powder (manufactured by Nippon Powder Pharmaceutical Co., Ltd.) and 10 g of enzyme lactase F "Amano" (manufactured by Amano Enzyme Co., Ltd.) derived from Aspergillus oryzae, add 2.5 liters of water to dissolve and suspend, and place in ℃ in an incubator, shaking occasionally and allowing it to react for 5 days. Then, add acetic acid, make the concentration of acetic acid be 1v / v%, and carry out heat treatment (120 ℃, 40 minutes) make it react, make enzyme inactivation simultaneously, this reaction solution is directly lyophilized, obtains brown powder 90 grams ( Sample 2).

Embodiment 3

[0066] Weigh 100 g of Tianqimo (manufactured by Yunnan Baiyao Group Co., Ltd.) and 10 g of Aspergillus niger-derived enzyme Cellulosin PE60 (manufactured by Hankyu Kyoei Bussan Co., Ltd.), and add 2.5 liters of water to dissolve it , suspended, placed in an incubator at 50°C, shaken from time to time, and allowed to react for 6 days. Then, add acetic acid, make the concentration of acetic acid be 1v / v%, and carry out heat treatment (120 ℃, 40 minutes) make it react, make enzyme inactivation simultaneously, this reaction solution is directly lyophilized, obtains brown powder 105 grams ( Sample 3).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Disclosed is an organolipid (a lipid occurring in an organ)-reducing agent and an alcohol metabolism promoter, each of which comprises, as an active ingredient, a composition produced by treating a ginseng in either one of the following steps (a) or (b) and further treating the treated ginseng in the other step: (a) contacting the ginseng with a microorganism or an enzyme; and (b) reacting the ginseng with an acid or an alkali. In the organolipid-reducing agent and the alcohol metabolism promoter, the step (a) may be a step of contacting the ginseng with an enzyme, and the step (b) may be a step of reacting the ginseng with an acid. In the organolipid-reducing agent and the alcohol metabolism promoter, the ginseng may be Tienchi ginseng. In the organolipid-reducing agent, the organ may be the liver. Also disclosed are a food and a pharmaceutical preparation both for reducing an organolipid, each of which comprises the organolipid-reducing agent. Further disclosed are a food and a pharmaceutical preparation both for promoting the alcohol metabolism, each of which comprises the alcohol metabolism promoter.

Description

technical field [0001] The present invention relates to an organ lipid lowering agent and an ethanol metabolism accelerator which use a composition obtained by specific treatment of medicinal ginseng as an active ingredient. [0002] This application claims priority based on Japanese Patent Application No. 2007-296485 for which it applied to Japan on November 15, 2007, and Japanese Patent Application No. 2007-331392 for which it applied to Japan on December 25, 2007, and uses the content here. Background technique [0003] In recent years, with changes in dietary life, opportunities to eat high-fat foods are increasing. Excessive intake of fat increases the risk of lifestyle-related diseases such as obesity, hyperlipidemia, diabetes, and high blood pressure. Therefore, it is desirable to regulate the amount of fat intake by adjusting food intake or perform appropriate exercise so that the intake of fat can be consumed in the form of energy Lose. However, the current situat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/25A23L1/30A61P1/16A61P3/06
CPCA23V2002/00A61K36/25A23L1/3002A23L33/105A61P1/16A61P3/06A61P39/02A61P43/00A23V2200/32A23V2250/2124
Inventor 松山浩子守口彻原马明子佐佐木阳子
Owner WAKUNAGA PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products